| 000 | 01195 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517230055.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a1432-0843 | ||
| 024 | 7 |
_a10.1007/s00280-018-3641-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatnaik, Amita | |
| 245 | 0 | 0 |
_aCorrection to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c09 2018 |
||
| 300 |
_a419 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Published Erratum | ||
| 700 | 1 | _aGordon, Michael | |
| 700 | 1 | _aTsai, Frank | |
| 700 | 1 | _aPapadopoulos, Kyriakos P | |
| 700 | 1 | _aRasco, Drew | |
| 700 | 1 | _aBeeram, Muralidhar | |
| 700 | 1 | _aFu, Siqing | |
| 700 | 1 | _aJanku, Filip | |
| 700 | 1 | _aHynes, Scott M | |
| 700 | 1 | _aGundala, Sushma R | |
| 700 | 1 | _aWillard, Melinda D | |
| 700 | 1 | _aZhang, Wei | |
| 700 | 1 | _aLin, Aimee Bence | |
| 700 | 1 | _aHong, David | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 82 _gno. 3 _gp. 419 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-018-3641-5 _zAvailable from publisher's website |
| 999 |
_c28638433 _d28638433 |
||